menu
    • menu

    Company profile for Generation Bio

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Generation Bio is an innovative genetic medicines company focused on creating a new classof gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporatesa proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable c...
    Generation Bio is an innovative genetic medicines company focused on creating a new classof gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporatesa proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Generation BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Generation Bio 301 Binney Street Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://generationbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Generation Bio Announces Third Quarter 2025 Financial Results
    Generation Bio Announces Third Quarter 2025 Financial Results

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181935/0/en/Generation-Bio-Announces-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Generation Bio Announces CEO Transition
    Generation Bio Announces CEO Transition

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3171465/0/en/Generation-Bio-Announces-CEO-Transition.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Generation Bio Lays Off 90% Staff, Including R&d Team
    Generation Bio Lays Off 90% Staff, Including R&d Team

    18 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/generation-jettisons-90-employees-due-lack-time-cash-develop-autoimmune-tech

    FIERCE BIOTECH
    18 Aug 2025
    Share Share
    Generation Bio Shares Data, Early T Cell Programs, Q2 Financials
    Generation Bio Shares Data, Early T Cell Programs, Q2 Financials

    12 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/12/3132126/0/en/Generation-Bio-Announces-New-Data-for-Its-Novel-ctLNP-Delivery-System-and-Early-T-Cell-Programs-and-Reports-Second-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    12 Aug 2025
    Share Share
    Generation Bio Announces 1-for-10 Reverse Stock Split
    Generation Bio Announces 1-for-10 Reverse Stock Split

    18 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/18/3117891/0/en/Generation-Bio-Announces-1-for-10-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    18 Jul 2025
    Share Share
    Generation Bio Grants Inducement Under Nasdaq Listing Rule
    Generation Bio Grants Inducement Under Nasdaq Listing Rule

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3111294/0/en/Generation-Bio-Announces-Inducement-Grant-under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search